Skip to the page

Data / Drug companies / Amici Pharma, Inc.

Amici Pharma, Inc.: 63 products in the FDA NDC directory, labeler code 69292

Amici Pharma, Inc. (labeler code 69292) lists 63 products in the FDA National Drug Code Directory, covering 26 finished drugs by generic name. By type: 63 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 15, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69292
Products in commercial distribution
63
Packages
111
Finished drugs by generic name
26
Prescription products
63
Over the counter products
0
Controlled substance products
Schedule II 2, Schedule III 4
Flagged as original packager
57 of 57 products that carry the flag
Started marketing in the last 12 months
30
Earliest marketing start
March 31, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)63100%

Products by type

TypeProductsShare
Prescription drugs63100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3860.3%
Capsule1015.9%
Tablet, film coated812.7%
Tablet, orally disintegrating57.9%
Solution/ drops11.6%
Solution11.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Amphetamine Sulfate69292-107TabletGeneric drugs (ANDA)June 15, 2026
Amphetamine Sulfate69292-106TabletGeneric drugs (ANDA)June 15, 2026
Bupropion Hydrochloride69292-602Tablet, film coatedGeneric drugs (ANDA)May 21, 2026
Bupropion Hydrochloride69292-601Tablet, film coatedGeneric drugs (ANDA)May 21, 2026
Terazosin Hydrochloride69292-204CapsuleGeneric drugs (ANDA)May 20, 2026
Terazosin Hydrochloride69292-203CapsuleGeneric drugs (ANDA)May 20, 2026
Terazosin Hydrochloride69292-202CapsuleGeneric drugs (ANDA)May 20, 2026
Terazosin Hydrochloride69292-201CapsuleGeneric drugs (ANDA)May 20, 2026
Pravastatin Sodium69292-104TabletGeneric drugs (ANDA)May 19, 2026
Pravastatin Sodium69292-103TabletGeneric drugs (ANDA)May 19, 2026
Pravastatin Sodium69292-102TabletGeneric drugs (ANDA)May 19, 2026
Pravastatin Sodium69292-101TabletGeneric drugs (ANDA)May 19, 2026
Gabapentin69292-642CapsuleGeneric drugs (ANDA)May 15, 2026
Gabapentin69292-641CapsuleGeneric drugs (ANDA)May 15, 2026
Gabapentin69292-640CapsuleGeneric drugs (ANDA)May 15, 2026
Butalbital, acetaminophen and caffeine69292-305CapsuleGeneric drugs (ANDA)April 10, 2026
Risperidone69292-575Tablet, orally disintegratingGeneric drugs (ANDA)April 1, 2026
Risperidone69292-574Tablet, orally disintegratingGeneric drugs (ANDA)April 1, 2026
Risperidone69292-573Tablet, orally disintegratingGeneric drugs (ANDA)April 1, 2026
Risperidone69292-572Tablet, orally disintegratingGeneric drugs (ANDA)April 1, 2026
Risperidone69292-571Tablet, orally disintegratingGeneric drugs (ANDA)April 1, 2026
Butalbital and acetaminophen69292-303TabletGeneric drugs (ANDA)March 15, 2026
Butalbital and acetaminophen69292-302TabletGeneric drugs (ANDA)March 15, 2026
Butalbital and acetaminophen69292-301TabletGeneric drugs (ANDA)March 15, 2026
Terbinafine hydrochloride69292-225TabletGeneric drugs (ANDA)February 18, 2026

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.